ARCHIVES

Cediranib/Olaparib Combination Nearly Doubles PFS in Phase II

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Fischinger Hints of “New Player” At FCRF; Gigliotti Named Cancer Control Science Director

December 12, 1986

Surveillance Treatment Option For Low-Risk Prostate Cancer

July 30, 2010

In Brief: Heavy Smokers More Resistant To Quitting,

March 10, 1995

Hong Succeeds Curran As AACR President, Horwitz Is President-Elect; 5 New Directors.

March 30, 2001

NCI-Approved Group, Center Clinical Trials Listed

May 25, 2007

Tobacco Research Council Awards Six New Grants

July 4, 1975